Gene Signature–Based Approach Identified MEK1/2 as a Potential Target Associated With Relapse After Anti-TNFα Treatment for Crohn’s Disease

por Gamo, Kanae, Okuzono, Yuumi, Yabuki, Masato, Ochi, Takashi, Sugimura, Kyoko, Sato, Yosuke, Sagara, Masaki, Hayashi, Hiroki, Ishimura, Yoshimasa, Nishimoto, Yutaka, Murakawa, Yusuke, Shiokawa, Zenyu, Gotoh, Masayuki, Miyazaki, Takahiro, Ebisuno, Yukihiko
Publicado 2018